Dhaka, Feb. 13 -- Unethical promotional practices and systemic inefficiencies in Bangladesh's pharmaceutical sector are making essential medicine unaffordable, undermining the country's progress towards Universal Health Coverage (UHC).

While Bangladesh's pharmaceutical industry meets 98 per cent of domestic medicine demand and exports to over 70 countries, concerns over pricing, regulatory oversight, and supply chain weaknesses persist. Experts argue that while cost-effective solutions are necessary, they should not come at the expense of quality or patient welfare.

These issues took centre stage at a debate on Thursday, titled "Holistic Strategy to Ensure Affordable Medicine Supply Chains Towards Realizing UHC" Organised by the Power a...